Single-center study is enrolling patients at Roswell Park Cancer Institute in Buffalo, New York. Argos Therapeutics Inc. (Nasdaq: ARGS) (“Argos”), an immuno-oncology company focused on the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results